APBA2BP Activators represent a class of compounds that influence various intracellular signaling pathways, leading to the functional enhancement of APBA2BP. Compounds like epinephrine, isoproterenol, and terbutaline act as adrenergic receptor agonists, which stimulate adenylyl cyclase resulting in increased cAMP levels. The elevated cAMP activates PKA, which can phosphorylate and enhance the activity of APBA2BP. Similarly, forskolin, a direct activator of adenylyl cyclase, and IBMX, a non-selective inhibitor of phosphodiesterases, also raise cAMP levels, further promoting PKA activity and the subsequent phosphorylation of APBA2BP, thus enhancing its function.
In addition to compounds that raise cAMP levels, other activators like PGE2 and dopamine engage with their respective G-protein-coupled receptors to initiate similar cAMP-PKA signaling cascades, potentially leading to the phosphorylation of APBA2BP. Histamine, through H2 receptor activation, follows the same route of increasing cAMP and activating PKA, which in turn can phosphorylate APBA2BP, leading to its functional enhancement.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which can lead to compensatory cellular responses and activation of alternative pathways that potentially converge on APBA2BP activation. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide is a selective inhibitor of PDE3 which increases cAMP levels in certain cells, potentially leading to PKA activation and subsequent phosphorylation and enhancement of APBA2BP activity. | ||||||